⌘K
Loading ticker…
As of 2026-08-24, bioAffinity Technologies, Inc. Common Stock (BIAF) has a 3-month relative strength percentile of 3 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 25. The current market Stance is 47.8 (Neutral). Sector: Industrials, ranked 6 of 11. Average daily range 13.0%, relative volume 0.27×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
BIAF appears in 1 ETF as of Apr 2026: DFAS at 0.00% weight, $16K notional.
Held by 2 ETFs · $229K across latest filings · largest weight 0.00% (VXF).
Top 1 by value, from SEC N-PORT-P filings dated Apr 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| DFASDimensional U.S. Small Cap ETF | 0.00% | $16K | new |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BIAF Jan avg: 12.50% median: 1.69% win: 50% σ: 35.07% n: 4 2022-09-02 → 2026-07-31 | BIAF Feb avg: -7.08% median: -20.61% win: 25% σ: 38.80% n: 4 2022-09-02 → 2026-07-31 | BIAF Mar avg: 52.89% median: -0.88% win: 50% σ: 141.06% n: 4 2022-09-02 → 2026-07-31 | BIAF Apr avg: 17.53% median: 12.23% win: 75% σ: 48.27% n: 4 2022-09-02 → 2026-07-31 | BIAF May avg: -20.35% median: -19.48% win: 0% σ: 19.10% n: 4 2022-09-02 → 2026-07-31 | BIAF Jun avg: -14.70% median: -5.00% win: 50% σ: 25.05% n: 4 2022-09-02 → 2026-07-31 | BIAF Jul avg: -0.23% median: 3.28% win: 50% σ: 17.05% n: 4 2022-09-02 → 2026-07-31 | BIAF Aug avg: -21.70% median: -23.63% win: 0% σ: 19.10% n: 3 2022-09-02 → 2026-07-31 (current) | BIAF Sep avg: -29.56% median: -45.99% win: 25% σ: 47.60% n: 4 2022-09-02 → 2026-07-31 | BIAF Oct avg: -10.54% median: -9.65% win: 25% σ: 17.36% n: 4 2022-09-02 → 2026-07-31 | BIAF Nov avg: -6.87% median: -10.15% win: 25% σ: 29.24% n: 4 2022-09-02 → 2026-07-31 | BIAF Dec avg: -24.65% median: -23.22% win: 0% σ: 12.18% n: 4 2022-09-02 → 2026-07-31 |